Skip to main content
PETV
OTC Industrial Applications And Services

PetVivo Ends VetStem License, Settles Disputes for $75K

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$0.642
Mkt Cap
$24.147M
52W Low
$0.6
52W High
$1.69
52W Position info
7.1% above low
Off High info
62% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

PETV is trading near its 52-week low of $0.6 (7.1% above the low).

Summary

PetVivo terminated its license agreement with VetStem, paying $75,000 to settle all disputes and returning PrecisePRP inventory. The move eliminates legal uncertainty and allows focus on core products, but the company remains under financial pressure.


Key Events · Legal and Risk Events · PETV

  • License Agreement Terminated

    Effective July 24, 2026, PetVivo and VetStem mutually terminated their Exclusive License and Supply Agreement, ending PetVivo's rights to the PrecisePRP product line.

  • Settlement Payment of $75,000

    To fully settle all disputes and extinguish prior financial obligations, PetVivo will pay $75,000 in two installments: $50,000 within 14 days and $25,000 within 30 business days.

  • Inventory Returned to VetStem

    All remaining PrecisePRP inventory—at least 1,828 vials—transfers to VetStem at no cost; PetVivo may owe additional fees if the inventory count falls short.

  • Warrant Remains Outstanding

    The previously issued warrant allowing VetStem to purchase 250,000 shares of PetVivo common stock remains in full force and effect, representing potential future dilution.


Analysis · PETV · Industrial Applications And Services

By terminating its exclusive license for the PrecisePRP product line, PetVivo has resolved all disputes with VetStem. The settlement requires a $75,000 payment and the return of inventory, though a warrant for 250,000 shares remains outstanding. Removing this legal overhang allows management to concentrate on its proprietary SPRYNG technology, but it also means surrendering a commercialized product line. The cost is modest relative to the company's financial distress—the recent 10-K flagged going concern risk and material weaknesses—so clearing this distraction is a small positive step, though it doesn't address the core cash burn problem.

How filings like this one have moved

In the 30 days to Oct 5, 2026, 29.2% of the 1496 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PETV was trading at $0.64 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $24.1M. The 52-week trading range was $0.60 to $1.69. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PETV - Latest Insights

PETV
Aug 14, 2026, 4:58 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.680
Real-time Price: $0.750 info
Change: +$0.070 (+10%) info
Market Cap: $28.463M info
PETV
Jul 28, 2026, 5:25 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.6423
Real-time Price: $0.750 info
Change: +$0.1077 (+17%) info
Market Cap: $28.463M info
PETV
Jul 27, 2026, 2:28 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.640
Real-time Price: $0.750 info
Change: +$0.110 (+17%) info
Market Cap: $28.463M info
PETV
Jun 29, 2026, 5:30 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.880
Real-time Price: $0.750 info
Change: -$0.130 (-15%) info
Market Cap: $28.463M info
PETV
Jun 29, 2026, 5:30 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.880
Real-time Price: $0.750 info
Change: -$0.130 (-15%) info
Market Cap: $28.463M info